Cargando…
The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization
The development of new effective vaccines strongly depends on adjuvants and formulations able to stimulate not only strong humoral responses against a certain pathogen but also effector as well as memory CD4+ and CD8+ T cells (Dubensky et al., 2013). However, the majority of vaccines licensed for hu...
Autores principales: | Ebensen, Thomas, Delandre, Simon, Prochnow, Blair, Guzmán, Carlos A., Schulze, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390046/ https://www.ncbi.nlm.nih.gov/pubmed/30838180 http://dx.doi.org/10.3389/fcimb.2019.00031 |
Ejemplares similares
-
Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Capacity
por: Ebensen, Thomas, et al.
Publicado: (2023) -
Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi
por: Matos, Marina N., et al.
Publicado: (2017) -
Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
por: Sanchez, Maria Victoria, et al.
Publicado: (2014) -
Cyclic-di-AMP Phosphodiesterase Elicits Protective Immune Responses Against Mycobacterium tuberculosis H37Ra Infection in Mice
por: Lu, Yanzhi, et al.
Publicado: (2022) -
Subunit Vaccine ESAT-6:c-di-AMP Delivered by Intranasal Route Elicits Immune Responses and Protects Against Mycobacterium tuberculosis Infection
por: Ning, Huanhuan, et al.
Publicado: (2021)